INCYTE CORPORATION Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INCYTE CORPORATION stock issued during period, value, issued for services for the quarter ending 2026-03-31 was $92.00K, a 12.20% increase year-over-year.
- INCYTE CORPORATION stock issued during period, value, issued for services for the quarter ending 2025-12-31 was $81.00K.
- INCYTE CORPORATION stock issued during period, value, issued for services for the quarter ending 2025-09-30 was $82.00K, a 2.50% increase year-over-year.
- INCYTE CORPORATION stock issued during period, value, issued for services for the quarter ending 2025-06-30 was $82.00K, a 2.50% increase year-over-year.
- INCYTE CORPORATION stock issued during period, value, issued for services for fiscal 2025 was $327.00K, a 1.87% increase from fiscal 2024.
- INCYTE CORPORATION stock issued during period, value, issued for services for fiscal 2024 was $321.00K, a 0.00% change from fiscal 2023.
- INCYTE CORPORATION stock issued during period, value, issued for services for fiscal 2023 was $321.00K, a 24.82% decline from fiscal 2022.
- INCYTE CORPORATION stock issued during period, value, issued for services for fiscal 2022 was $427.00K, a 1.61% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-03-31 | $92.00K 10-Q · filed 2026-04-28 | $337.00K derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-12-31 | $81.00K derived: 10-K 12 month − 3 quarters · filed 2026-02-10 | $327.00K 10-K · filed 2026-02-10 |
| 2025-09-30 | $82.00K 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $82.00K 10-Q · filed 2025-10-28 | |
| 2025-03-31 | $82.00K 10-Q · filed 2026-04-28 | |
| 2024-12-31 | $321.00K 10-K · filed 2026-02-10 | |
| 2024-09-30 | $80.00K 10-Q · filed 2025-10-28 | |
| 2024-06-30 | $80.00K 10-Q · filed 2025-10-28 | |
| 2024-03-31 | $80.00K 10-Q · filed 2025-10-28 | |
| 2023-12-31 | $321.00K 10-K · filed 2026-02-10 | |
| 2023-09-30 | $80.00K 10-Q · filed 2024-10-29 | |
| 2023-06-30 | $80.00K 10-Q · filed 2024-10-29 | |
| 2023-03-31 | $80.00K 10-Q · filed 2024-10-29 | |
| 2022-12-31 | $427.00K 10-K · filed 2025-02-10 | |
| 2022-09-30 | $94.00K 10-Q · filed 2023-10-31 | |
| 2022-06-30 | $109.00K 10-Q · filed 2023-10-31 | |
| 2022-03-31 | $112.00K 10-Q · filed 2023-10-31 | |
| 2021-12-31 | $434.00K 10-K · filed 2024-02-13 | |
| 2021-09-30 | $108.00K 10-Q · filed 2022-11-01 | |
| 2021-06-30 | $109.00K 10-Q · filed 2022-11-01 | |
| 2021-03-31 | $108.00K 10-Q · filed 2022-11-01 | |
| 2020-12-31 | $546.00K 10-K · filed 2023-02-07 | |
| 2020-09-30 | $131.00K 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $139.00K 10-Q · filed 2021-11-02 | |
| 2020-03-31 | $145.00K 10-Q · filed 2021-11-02 | |
| 2019-12-31 | $487.00K 10-K · filed 2022-02-08 | |
| 2019-09-30 | $129.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $123.00K 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $104.00K 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $344.00K 10-K · filed 2021-02-09 | |
| 2018-09-30 | $86.00K 10-Q · filed 2019-10-29 | |
| 2018-06-30 | $85.00K 10-Q · filed 2019-10-29 | |
| 2018-03-31 | $87.00K 10-Q · filed 2019-10-29 | |
| 2017-12-31 | $294.00K 10-K · filed 2020-02-13 | |
| 2016-12-31 | $294.00K 10-K · filed 2019-02-14 | |
| 2015-12-31 | $218.00K 10-K · filed 2018-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |